Oversimplified, the RCN and other interrelated valuation methodologies for a refining operation lead to some interesting conclusions.
In the case of a topping unit, particularly a unit that can digest high API, low sulphur sweet feedstock, there is some inherent value - you can see that in the Valero activity.
The sunk cost/investment in the Nixon unit has value - the assets, operations knowledge, and location might all combine into something positive, if there were a regional refiner who needed to increase throughput, or adjust for light sweet crude to augment existing front-end capability that was tuned for heavy or sour crude.
If there is pipeline infrastructure nearby, or rail infrastructure to use the Nixon unit intermediate to feed a downstream system, there might be something to salvage. Knocking out transportation-related margin hits might be a key.
Adjusting operations to minimize down-time is another opportunity for an acquirer/partner - some things, like making the electrical mains infrastructure more resilient, to reduce downtime is relatively inexpensive, and increases in uptime, reduce repeated shutdown/startup hysteresis that impact margin.
It looks like Nixon may have stabilization capability, and was apparently supplying contract jet fuel from kerosene conversion - that is a positive. It lacks a required de-sulphuring capability for transportation-grade diesel, which is likely to expensive to add under current circumstances.
The drilling fluids thing is a quirk - that might be regional. Hydrocarbon-based fluids for well-bore control are specialty. I don't know enough about the regional issues to comment. That seems to have been part of the Nixon unit output.
A regional refiner would be the best bet, if there is one who needs light crude feedstock.
Recent BDCO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 08:13:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:22:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:49:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 10:23:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 02:09:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 07:26:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 05:45:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2023 06:56:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/23/2023 09:19:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 11:15:12 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:05:56 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM